"Stroke Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.
| Descriptor ID |
D013318
|
| MeSH Number(s) |
E01.370.370.380.150.700 G09.330.380.124.882
|
| Concept/Terms |
Stroke Volume- Stroke Volume
- Stroke Volumes
- Volume, Stroke
- Volumes, Stroke
Ventricular End-Systolic Volume- Ventricular End-Systolic Volume
- End-Systolic Volume, Ventricular
- End-Systolic Volumes, Ventricular
- Ventricular End Systolic Volume
- Ventricular End-Systolic Volumes
- Volume, Ventricular End-Systolic
- Volumes, Ventricular End-Systolic
Ventricular Ejection Fraction- Ventricular Ejection Fraction
- Ejection Fraction, Ventricular
- Ejection Fractions, Ventricular
- Fraction, Ventricular Ejection
- Fractions, Ventricular Ejection
- Ventricular Ejection Fractions
Ventricular End-Diastolic Volume- Ventricular End-Diastolic Volume
- End-Diastolic Volume, Ventricular
- End-Diastolic Volumes, Ventricular
- Ventricular End Diastolic Volume
- Ventricular End-Diastolic Volumes
- Volume, Ventricular End-Diastolic
- Volumes, Ventricular End-Diastolic
|
Below are MeSH descriptors whose meaning is more general than "Stroke Volume".
Below are MeSH descriptors whose meaning is more specific than "Stroke Volume".
This graph shows the total number of publications written about "Stroke Volume" by people in this website by year, and whether "Stroke Volume" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 2 | 5 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stroke Volume" by people in Profiles.
-
Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T-cell therapy. Eur J Haematol. 2024 Jan; 112(1):102-110.
-
Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects. Heart Rhythm. 2023 11; 20(11):1491-1501.
-
Renal Denervation Helps Preserve the Ejection Fraction by Preserving Endocardial-Endothelial Function during Heart Failure. Int J Mol Sci. 2023 Apr 15; 24(8).
-
Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2023 01 15; 187:84-92.
-
A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies. J Interv Card Electrophysiol. 2023 Jan; 66(1):161-175.
-
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy. Heart Rhythm. 2022 08; 19(8):1263-1271.
-
Transthyretin deposition alters cardiomyocyte sarcomeric architecture, calcium transients, and contractile force. Physiol Rep. 2022 03; 10(5):e15207.
-
Orthopaedic Nursing and Heart Failure: A Review of Pathophysiology and Management. Orthop Nurs. 2022 Jan-Feb 01; 41(1):25-34.
-
Mortality benefit of catheter ablation versus medical therapy in atrial fibrillation: An RCT only meta-analysis. J Cardiovasc Electrophysiol. 2022 02; 33(2):178-193.
-
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021 06; 10(11):3565-3574.